If investors don't like the news and think this will impact earnings, then they'd probably sell down and SP will drop. If what they were testing isn't a big part of their business, then maybe it won't impact it as much.
All down to how shareholders view the news.
ResMed heart attack trial stopped after putting patients at risk, page-3
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$34.66 |
Change
-0.100(0.29%) |
Mkt cap ! $21.25B | |||
| Open | High | Low | Value | Volume |
| $34.65 | $34.82 | $34.53 | $45.12M | 1.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $34.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $34.76 | 632 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| RMD (ASX) Chart |